Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Surgical Endoscopy|November 18, 2020
Inequalities in access to minimally invasive general surgery: a comprehensive nationwide analysis across 20 yearsMarcel André Schneider, Daniel Gero, Matteo Müller, et al.
International Journal of Colorectal Disease|May 9, 2018
Risk factors for early postoperative complications and length of hospital stay in ileocecal resection and right hemicolectomy for Crohn's disease: a single-center experienceChristian Galata, Christel Weiss, Julia Hardt, et al.
Langenbeck'S Archives of Surgery|July 4, 2023
The value of intraoperative dynamic liver function test ICG in predicting postoperative complications in patients undergoing staged hepatectomy: a pilot studyKaroline Horisberger, Fabian Rössler, Christian E Oberkofler, et al.
International Journal of Colorectal Disease|January 26, 2020
Direct intraoperative assessment of total mesorectal excision specimens by expert pathologists in patients with very low rectal cancer prevents unnecessary abdominoperineal resectionsAndreas Rickenbacher, Jennifer Watson, Karoline Horisberger, et al.
Journal of Clinical Gastroenterology|June 28, 2017
Clinical and Histopathologic Features of Colorectal Adenocarcinoma in Crohn's DiseaseChristian Galata, Daniela Hirsch, Wolfgang Reindl, et al.
World Journal of Surgical Oncology|August 4, 2018
Impact of adjuvant chemotherapy on patients with ypT0-2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospitalChristian Galata, Kirsten Merx, Sabine Mai, et al.
Onkologie|March 20, 2009
Can dynamic MR imaging predict response in patients with rectal cancer undergoing cetuximab-based neoadjuvant chemoradiation?Dietmar J Dinter, Karoline Horisberger, Christian Zechmann, et al.
Onkologie|September 15, 2010
Annexin and survivin in locally advanced rectal cancer: indicators of resistance to preoperative chemoradiotherapy?Karoline Horisberger, Philipp Erben, Philipp Ströbel, et al.
Anti-Cancer Drugs|May 14, 2009
Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancerKaroline Horisberger, Philipp Erben, Benjamin Muessle, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2010
KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancerPhilipp Erben, Philipp Ströbel, Karoline Horisberger, et al.
Pageof 3